These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26421827)

  • 1. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.
    De Angelis R; Minicozzi P; Sant M; Dal Maso L; Brewster DH; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A;
    Eur J Cancer; 2015 Oct; 51(15):2254-2268. PubMed ID: 26421827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
    Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
    Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data.
    Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I;
    Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
    Sant M; Vener C; Lillini R; Rossi S; Bonfarnuzzo S; Marcos-Gragera R; Maynadié M; Innos K; Paapsi K; Visser O; Bernasconi A; Demuru E; Di Benedetto C; Mousavi SM; Blum M; Went P; Serraino D; Bennett D; Sánchez MJ; De Angelis R;
    Lancet Oncol; 2024 Jun; 25(6):731-743. PubMed ID: 38703784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).
    Mounier M; Bossard N; Remontet L; Belot A; Minicozzi P; De Angelis R; Capocaccia R; Iwaz J; Monnereau A; Troussard X; Sant M; Maynadié M; Giorgi R; ;
    Lancet Haematol; 2015 Nov; 2(11):e481-91. PubMed ID: 26686258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
    Gatta G; Botta L; Rossi S; Aareleid T; Bielska-Lasota M; Clavel J; Dimitrova N; Jakab Z; Kaatsch P; Lacour B; Mallone S; Marcos-Gragera R; Minicozzi P; Sánchez-Pérez MJ; Sant M; Santaquilani M; Stiller C; Tavilla A; Trama A; Visser O; Peris-Bonet R;
    Lancet Oncol; 2014 Jan; 15(1):35-47. PubMed ID: 24314616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in survival of adult patients with haematological malignancies in Europe since 1978. EUROCARE Working Group.
    Carli PM; Coebergh JW; Verdecchia A
    Eur J Cancer; 1998 Dec; 34(14 Spec No):2253-63. PubMed ID: 10070296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.
    De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; Visser O; Brenner H; Ardanaz E; Bielska-Lasota M; Engholm G; Nennecke A; Siesling S; Berrino F; Capocaccia R;
    Lancet Oncol; 2014 Jan; 15(1):23-34. PubMed ID: 24314615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study.
    Botta L; Gatta G; Capocaccia R; Stiller C; Cañete A; Dal Maso L; Innos K; Mihor A; Erdmann F; Spix C; Lacour B; Marcos-Gragera R; Murray D; Rossi S;
    Lancet Oncol; 2022 Dec; 23(12):1525-1536. PubMed ID: 36400102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978--1992: the EUROCARE study.
    Coebergh JW; Pastore G; Gatta G; Corazziari I; Kamps W;
    Eur J Cancer; 2001 Apr; 37(6):687-94. PubMed ID: 11311642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5.
    Trama A; Botta L; Foschi R; Ferrari A; Stiller C; Desandes E; Maule MM; Merletti F; Gatta G;
    Lancet Oncol; 2016 Jul; 17(7):896-906. PubMed ID: 27237614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006.
    Storm HH; Klint A; Tryggvadóttir L; Gislum M; Engholm G; Bray F; Hakulinen T
    Acta Oncol; 2010 Jun; 49(5):694-712. PubMed ID: 20491526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States.
    Sant M; Allemani C; De Angelis R; Carbone A; de Sanjosè S; Gianni AM; Giraldo P; Marchesi F; Marcos-Gragera R; Martos-Jiménez C; Maynadié M; Raphael M; Berrino F;
    Eur J Cancer; 2008 Mar; 44(4):579-87. PubMed ID: 18242077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries.
    Ssenyonga N; Stiller C; Nakata K; Shalkow J; Redmond S; Bulliard JL; Girardi F; Fowler C; Marcos-Gragera R; Bonaventure A; Saint-Jacques N; Minicozzi P; De P; Rodríguez-Barranco M; Larønningen S; Di Carlo V; Mägi M; Valkov M; Seppä K; Wyn Huws D; Coleman MP; Allemani C;
    Lancet Child Adolesc Health; 2022 Jun; 6(6):409-431. PubMed ID: 35468327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood cancer survival in Europe.
    Gatta G; Corazziari I; Magnani C; Peris-Bonet R; Roazzi P; Stiller C;
    Ann Oncol; 2003; 14 Suppl 5():v119-27. PubMed ID: 14684502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.
    Berrino F; De Angelis R; Sant M; Rosso S; Bielska-Lasota M; Coebergh JW; Santaquilani M;
    Lancet Oncol; 2007 Sep; 8(9):773-83. PubMed ID: 17714991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study.
    Gatta G; Luksch R; Coleman MP; Corazziari I;
    Eur J Cancer; 2001 Apr; 37(6):695-702. PubMed ID: 11311643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.